Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Alba Guijarro Belmar; Anna Varone; Martin  Rugema Baltzer; Saurav  Kataria; Ezgi  Tanriver-Ayder; Ralf  Watzlawick; Emily Sena; Catriona Cunningham; Ann Rajnicek; Malcolm R. Macleod; Wenlong Huang; Gillian L Currie; Sarah K.  McCann

doi:10.1038/s41393-022-00811-z

Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Alba Guijarro Belmar, Anna Varone, Martin Rugema Baltzer, Saurav Kataria, Ezgi Tanriver-Ayder, Ralf Watzlawick, Emily Sena, Catriona Cunningham, Ann Rajnicek, Malcolm R. Macleod, Wenlong Huang^* (Corresponding Author), Gillian L Currie, Sarah K. McCann

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Study Design: Systematic review and meta-analysis of preclinical literature.
Objectives: To assess the effects of biomaterial-based combination (BMC) strategies for the treatment of Spinal Cord Injury (SCI), the effects of individual biomaterials in the context of BMC strategies, and the factors influencing their efficacy. To assess the effects of different preclinical testing paradigms in BMC strategies.
Methods: We performed a systematic literature search of Embase, Web of Science and PubMed. All controlled preclinical studies describing an in vivo or in vitro model of SCI that tested a biomaterial in combination with at least one other regenerative strategy (cells, drugs, or both) were included. Two review authors conducted the study selection independently, extracted study characteristics independently and assessed study quality using a modified CAMARADES checklist. Effect size measures were combined using random-effects models and heterogeneity was explored using meta-regression with tau2, I2 and R2 statistics. We tested for small-study effects using funnel plot–based methods.
Results: 134 publications were included, testing over 100 different BMC strategies. Overall, treatment with BMC therapies improved locomotor recovery by 25.3% (95% CI, 20.3-30.3; n=102) and in vivo axonal regeneration by 1.6SD (95% CI 1.2-2SD; n=117) in comparison with injury only controls.
Conclusion: BMC strategies improve locomotor outcomes after experimental SCI. Our comprehensive study highlights gaps in current knowledge and provides a foundation for the design of future experiments.

Original language	English
Pages (from-to)	1041-1049
Number of pages	9
Journal	Spinal Cord
Volume	60
Issue number	12
Early online date	23 May 2022
DOIs	https://doi.org/10.1038/s41393-022-00811-z
Publication status	Published - 1 Dec 2022

Bibliographical note

Funding
This work was supported by the Institute of Medical Sciences of the University of Aberdeen, International Spinal Research Trust, Scottish Rugby Union, RS McDonald Charitable Trust and The European Union’s Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant agreement no. 702213).

Data Availability Statement

The statistical analysis code and datasets analysed during this study are openly available from the Open Science Framework at https://osf.io/bgw73/.

Supplementary information
The online version contains supplementary material
available at https://doi.org/10.1038/s41393-022-00811-z.

Keywords

FUNCTIONAL RECOVERY
GENE-THERAPY
INJURY
REGENERATION
DELIVERY
DESIGN
CELLS
MODEL

Access to Document

10.1038/s41393-022-00811-zLicence: CC BY

Guijarro-Belmar_etal_SC_Effectiveness-Of_Biomaterial_VoR
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/.
Final published version, 1.07 MBLicence: CC BY

Cite this

Guijarro Belmar, A., Varone, A., Rugema Baltzer, M., Kataria, S., Tanriver-Ayder, E., Watzlawick, R., Sena, E., Cunningham, C., Rajnicek, A., Macleod, M. R., Huang, W., Currie, G. L., & McCann, S. K. (2022). Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature. Spinal Cord, 60(12), 1041-1049. https://doi.org/10.1038/s41393-022-00811-z

Guijarro Belmar, A, Varone, A, Rugema Baltzer, M, Kataria, S, Tanriver-Ayder, E, Watzlawick, R, Sena, E, Cunningham, C , Rajnicek, A, Macleod, MR, Huang, W, Currie, GL & McCann, SK 2022, 'Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature', Spinal Cord, vol. 60, no. 12, pp. 1041-1049. https://doi.org/10.1038/s41393-022-00811-z

@article{65364821be404be7a82141fdef3079ae,

title = "Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature",

abstract = "Study Design: Systematic review and meta-analysis of preclinical literature.Objectives: To assess the effects of biomaterial-based combination (BMC) strategies for the treatment of Spinal Cord Injury (SCI), the effects of individual biomaterials in the context of BMC strategies, and the factors influencing their efficacy. To assess the effects of different preclinical testing paradigms in BMC strategies.Methods: We performed a systematic literature search of Embase, Web of Science and PubMed. All controlled preclinical studies describing an in vivo or in vitro model of SCI that tested a biomaterial in combination with at least one other regenerative strategy (cells, drugs, or both) were included. Two review authors conducted the study selection independently, extracted study characteristics independently and assessed study quality using a modified CAMARADES checklist. Effect size measures were combined using random-effects models and heterogeneity was explored using meta-regression with tau2, I2 and R2 statistics. We tested for small-study effects using funnel plot–based methods.Results: 134 publications were included, testing over 100 different BMC strategies. Overall, treatment with BMC therapies improved locomotor recovery by 25.3% (95% CI, 20.3-30.3; n=102) and in vivo axonal regeneration by 1.6SD (95% CI 1.2-2SD; n=117) in comparison with injury only controls. Conclusion: BMC strategies improve locomotor outcomes after experimental SCI. Our comprehensive study highlights gaps in current knowledge and provides a foundation for the design of future experiments. ",

keywords = "FUNCTIONAL RECOVERY, GENE-THERAPY, INJURY, REGENERATION, DELIVERY, DESIGN, CELLS, MODEL",

author = "{Guijarro Belmar}, Alba and Anna Varone and {Rugema Baltzer}, Martin and Saurav Kataria and Ezgi Tanriver-Ayder and Ralf Watzlawick and Emily Sena and Catriona Cunningham and Ann Rajnicek and Macleod, {Malcolm R.} and Wenlong Huang and Currie, {Gillian L} and McCann, {Sarah K.}",

note = "Funding This work was supported by the Institute of Medical Sciences of the University of Aberdeen, International Spinal Research Trust, Scottish Rugby Union, RS McDonald Charitable Trust and The European Union{\textquoteright}s Horizon 2020 research and innovation programme (Marie Sk{\l}odowska-Curie grant agreement no. 702213). ",

year = "2022",

month = dec,

day = "1",

doi = "10.1038/s41393-022-00811-z",

language = "English",

volume = "60",

pages = "1041--1049",

journal = "Spinal Cord",

number = "12",

}

TY - JOUR

T1 - Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

AU - Guijarro Belmar, Alba

AU - Varone, Anna

AU - Rugema Baltzer, Martin

AU - Kataria, Saurav

AU - Tanriver-Ayder, Ezgi

AU - Watzlawick, Ralf

AU - Sena, Emily

AU - Cunningham, Catriona

AU - Rajnicek, Ann

AU - Macleod, Malcolm R.

AU - Huang, Wenlong

AU - Currie, Gillian L

AU - McCann, Sarah K.

N1 - Funding This work was supported by the Institute of Medical Sciences of the University of Aberdeen, International Spinal Research Trust, Scottish Rugby Union, RS McDonald Charitable Trust and The European Union’s Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant agreement no. 702213).

PY - 2022/12/1

Y1 - 2022/12/1

N2 - Study Design: Systematic review and meta-analysis of preclinical literature.Objectives: To assess the effects of biomaterial-based combination (BMC) strategies for the treatment of Spinal Cord Injury (SCI), the effects of individual biomaterials in the context of BMC strategies, and the factors influencing their efficacy. To assess the effects of different preclinical testing paradigms in BMC strategies.Methods: We performed a systematic literature search of Embase, Web of Science and PubMed. All controlled preclinical studies describing an in vivo or in vitro model of SCI that tested a biomaterial in combination with at least one other regenerative strategy (cells, drugs, or both) were included. Two review authors conducted the study selection independently, extracted study characteristics independently and assessed study quality using a modified CAMARADES checklist. Effect size measures were combined using random-effects models and heterogeneity was explored using meta-regression with tau2, I2 and R2 statistics. We tested for small-study effects using funnel plot–based methods.Results: 134 publications were included, testing over 100 different BMC strategies. Overall, treatment with BMC therapies improved locomotor recovery by 25.3% (95% CI, 20.3-30.3; n=102) and in vivo axonal regeneration by 1.6SD (95% CI 1.2-2SD; n=117) in comparison with injury only controls. Conclusion: BMC strategies improve locomotor outcomes after experimental SCI. Our comprehensive study highlights gaps in current knowledge and provides a foundation for the design of future experiments.

AB - Study Design: Systematic review and meta-analysis of preclinical literature.Objectives: To assess the effects of biomaterial-based combination (BMC) strategies for the treatment of Spinal Cord Injury (SCI), the effects of individual biomaterials in the context of BMC strategies, and the factors influencing their efficacy. To assess the effects of different preclinical testing paradigms in BMC strategies.Methods: We performed a systematic literature search of Embase, Web of Science and PubMed. All controlled preclinical studies describing an in vivo or in vitro model of SCI that tested a biomaterial in combination with at least one other regenerative strategy (cells, drugs, or both) were included. Two review authors conducted the study selection independently, extracted study characteristics independently and assessed study quality using a modified CAMARADES checklist. Effect size measures were combined using random-effects models and heterogeneity was explored using meta-regression with tau2, I2 and R2 statistics. We tested for small-study effects using funnel plot–based methods.Results: 134 publications were included, testing over 100 different BMC strategies. Overall, treatment with BMC therapies improved locomotor recovery by 25.3% (95% CI, 20.3-30.3; n=102) and in vivo axonal regeneration by 1.6SD (95% CI 1.2-2SD; n=117) in comparison with injury only controls. Conclusion: BMC strategies improve locomotor outcomes after experimental SCI. Our comprehensive study highlights gaps in current knowledge and provides a foundation for the design of future experiments.

KW - FUNCTIONAL RECOVERY

KW - GENE-THERAPY

KW - INJURY

KW - REGENERATION

KW - DELIVERY

KW - DESIGN

KW - CELLS

KW - MODEL

UR - http://www.scopus.com/inward/record.url?scp=85130764305&partnerID=8YFLogxK

U2 - 10.1038/s41393-022-00811-z

DO - 10.1038/s41393-022-00811-z

M3 - Review article

C2 - 35606413

VL - 60

SP - 1041

EP - 1049

JO - Spinal Cord

JF - Spinal Cord

IS - 12

ER -

Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Abstract

Bibliographical note

Data Availability Statement

Keywords

Access to Document

Other files and links

Fingerprint

Data from: Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Cite this

Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Abstract

Bibliographical note

Data Availability Statement

Keywords

Access to Document

Other files and links

Fingerprint

Datasets

Data from: Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

Cite this